This report provides an overview of the main findings of the 2020–2021 harmonised AMR monitoring in Salmonella spp., Campylobacter jejuni and C. coli in humans and food-producing animals and relevant meat thereof.
This report provides an updated overview on the progress of national COVID-19 vaccination strategies and deployment in European Union/European Economic Area (EU/EEA) countries, including updates on overall vaccine uptake and uptake by target group and vaccination strategies and policies.
Nipah virus (NiV) is an emerging zoonotic virus that can be transmitted to humans from animals (both wild and domestic). Fruit bats of the Pteropodidae family are the natural hosts of Nipah virus. NiV infection can be asymptomatic or mild (subclinical), but it also causes acute respiratory illness and fatal encephalitis.
Nipah virus (NiV) is an emerging zoonotic virus that can be transmitted to humans from animals (both wild and domestic). Fruit bats of the Pteropodidae family are the natural hosts of Nipah virus.
What is avian influenza (bird flu)? Why are we concerned about bird flu outbreaks? What are the control measures in birds and animals? How do outbreaks of avian influenza spread? etc.
Seasonal influenza activity is still widespread in the EU/EEA, with a slight increase in positivity in sentinel primary care starting from week 5/2023 related to increased type B virus circulation.
This protocol presents a common methodology to estimate vaccine effectiveness (VE) for COVID-19, using established health data registries in participating EU/EEA Member States.
This core protocol for ECDC studies of vaccine effectiveness against hospitalisation with Severe Acute Respiratory Infection laboratory-confirmed with SARS-CoV-2 or with influenza, version 2.0, represents an update to the main elements for a multi-country hospital-based study of COVID-19 vaccine effectiveness in patients hospitalised with Severe Acute Respiratory Infection (SARI), already published as version 1.0.
Europe has agreed on measures to be applied in aviation in response to the specific localised worsening of the COVID-19 epidemiological situation in China, making recommendations which could potentially also be applied in other geographical regions in similar situations.